Skip to main content
. 2023 Sep 1;102(35):e34405. doi: 10.1097/MD.0000000000034405

Table 5.

Results of subgroup analysis based on factors related to coronavirus mortality in terms of demographics, clinical characteristics, and comorbidities.

Risk factors Effect measures Numbers of study Effect size (95% CI) Heterogeneity Egger’s test P
I2 value
Advanced age pHR 4 3.73(2.27–5.19) 44.4 0.145 .109
pOR 7 1.04(1.02–1.06) 93.1 0.000 .000
Male pHR 0
pOR 3 1.23(1.07–1.40) 25.9 0.259 NA
Female pHR 0
pOR 1 0.220(0.059–0.827)
DM pHR 0
pOR 3 1.26(1.01–1.51) 0.0 0.552 NA
HTN pHR 0
pOR 3 1.56(1.27–1.85) 0.0 0.409 NA
CKD pHR 2 5.43(0.18–10.67) 0.0 0.964 NA
pOR 1 3.398(2.45–4.71)
Severe or critical condition pHR 1 14.05 (6.3–15.67)
pOR 2 9.04(3.14–14.94) 0.0 0.441 NA

CKD = chronic kidney disease, DM = diabetes mellitus, HTN = hypertension, NA = not available, pHR = pooled hazard ratio, pOR = pooled odds ratio.